New data on Orqis Medical's Cancion CRS to be reported at ACC
Lake Forest, Calif. March 7, 2005 Newly analyzed research on Orqis Medical's Cancion CRS cardiac recovery system for treating congestive heart failure will be presented at the Annual Scientific Session of the American College of Cardiology (ACC), held in Orlando, Florida (March 6-9). ...... The data suggests that patients with acutely decompensated chronic heart failure may benefit from the fi...Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
Orqis Medical Corp. today announced that the U.S. Food and Drug Administration has approved an expansion of the Cancion CRS ...The Cancion CRS therapy is a percutaneous cardiac recovery system being studied for its ability to create a "rest-to-recovery" environment for congestive heart failure (CHF) patients. Enrollment in the Multicenter trial of the Orqis Medical CRS for the ENhanced Treatment...